Contreras-Duarte Susana, Varas Pablo, Awad Fernanda, Busso Dolores, Rigotti Attilio
Rev Chilena Infectol. 2014 Feb;31(1):34-43. doi: 10.4067/S0716-10182014000100005.
High density lipoproteins (HDL) are responsible of reverse cholesterol transport and play an important antiatherogenic role. In recent years, several studies suggest that HDL have additional functions, including a possible anti-inflammatory activity in infectious conditions. Furthermore, available evidence indicates that the presence of lipopolysaccharide (LPS) within the circulation during infectious states induced by gram-negative bacteria may be involved in the decrease in HDL cholesterol levels and changes in lipoprotein composition, which have been associated with a higher mortality due to sepsis in animal models and in humans. In this article, we review this subject and also discuss possible mechanisms that explain the positive impact achieved by native HDL, reconstituted HDL, or HDL apolipoprotein peptides on the inflammatory response and mortality in models of endotoxemia. In this regard, it has been proposed that one of the mechanisms by which HDL protect against sepsis may be mediated by its binding ability and/or neutralizing capacity on LPS, avoiding an excessive response of the immune system. Thus, increasing blood levels of HDL and/or parenteral HDL administration may represent a new anti-inflammatory tool for managing septic states in humans.
高密度脂蛋白(HDL)负责逆向胆固醇转运,并发挥重要的抗动脉粥样硬化作用。近年来,多项研究表明HDL具有其他功能,包括在感染状态下可能具有的抗炎活性。此外,现有证据表明,革兰氏阴性菌引起的感染状态下循环中脂多糖(LPS)的存在可能与HDL胆固醇水平降低和脂蛋白组成变化有关,在动物模型和人类中,这些变化与败血症导致的更高死亡率相关。在本文中,我们回顾了这一主题,并讨论了解释天然HDL、重组HDL或HDL载脂蛋白肽对内毒素血症模型中的炎症反应和死亡率产生积极影响的可能机制。在这方面,有人提出HDL预防败血症的机制之一可能是通过其对LPS的结合能力和/或中和能力介导的,从而避免免疫系统的过度反应。因此,提高血液中HDL水平和/或胃肠外给予HDL可能是一种治疗人类败血症状态的新的抗炎手段。